Description
Ipamorelin (CAS: 170851-70-4) (NNC 26-0161) is a synthetic pentapeptide and selective agonist of the ghrelin/growth hormone secretagogue receptor (GHS-R1a), supplied by Nextday Peptides for laboratory and analytical research applications. Developed from the GHRP-1 peptide family, Ipamorelin is distinguished by its high receptor selectivity in experimental models. Each vial is independently verified to ≥99% HPLC purity with a Certificate of Analysis available on request. For scientific research use only.
Why Research Laboratories Select Ipamorelin
Ipamorelin is among the most studied selective growth hormone secretagogue receptor agonists in current endocrine and pituitary research. Its high selectivity for GHS-R1a in experimental models — without significant activity on other pituitary hormone pathways – makes it a valuable reference compound for laboratories investigating GH secretagogue signaling, receptor pharmacology, and comparative GHRP studies.
- Synthetic pentapeptide – 5 amino acid sequence with non-proteinogenic residues for receptor selectivity
- Selective GHS-R1a agonist – studied for minimal cross-reactivity with other pituitary hormone systems in research models
- Activates Gq/PLC-dependent calcium signaling pathways in experimental systems
- Referenced in peer-reviewed literature including Journal of Endocrinology and Growth Hormone & IGF Research
- Lyophilized format ensures stability and reproducibility across experimental runs

Reviews
There are no reviews yet.